HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Beneficial effects of a long-term oral L-arginine treatment added to a hypocaloric diet and exercise training program in obese, insulin-resistant type 2 diabetic patients.

Abstract
Because chronic L-arginine supplementation improves insulin sensitivity and endothelial function in nonobese type 2 diabetic patients, the aim of this study was to evaluate the effects of a long-term oral L-arginine therapy on adipose fat mass (FM) and muscle free-fat mass (FFM) distribution, daily glucose levels, insulin sensitivity, endothelial function, oxidative stress, and adipokine release in obese type 2 diabetic patients with insulin resistance who were treated with a combined period of hypocaloric diet and exercise training. Thirty-three type 2 diabetic patients participated in a hypocaloric diet plus an exercise training program for 21 days. Furthermore, they were divided into two groups in randomized order: the first group was also treated with L-arginine (8.3 g/day), and the second group was treated with placebo. Although in the placebo group body weight, waist circumference, daily glucose profiles, fructosamine, insulin, and homeostasis model assessment index significantly decreased, L-arginine supplementation further decreased FM (P < 0.05) and waist circumference (P < 0.0001), preserving FFM (P < 0.03), and improved mean daily glucose profiles (P < 0.0001) and fructosamine (P < 0.03). Moreover, change in area under the curve of cGMP (second messenger of nitric oxide; P < 0.001), superoxide dismutase (index of antioxidant capacity; P < 0.01), and adiponectin levels (P < 0.02) increased, whereas basal endothelin-1 levels (P < 0.01) and leptin-to-adiponectin ratio (P < 0.05) decreased in the L-arginine group. Long-term oral L-arginine treatment resulted in an additive effect compared with a diet and exercise training program alone on glucose metabolism and insulin sensitivity. Furthermore, it improved endothelial function, oxidative stress, and adipokine release in obese type 2 diabetic patients with insulin resistance.
AuthorsPietro Lucotti, Emanuela Setola, Lucilla D Monti, Elena Galluccio, Sabrina Costa, Emilia P Sandoli, Isabella Fermo, Giovanni Rabaiotti, Roberto Gatti, PierMarco Piatti
JournalAmerican journal of physiology. Endocrinology and metabolism (Am J Physiol Endocrinol Metab) Vol. 291 Issue 5 Pg. E906-12 (Nov 2006) ISSN: 0193-1849 [Print] United States
PMID16772327 (Publication Type: Journal Article, Randomized Controlled Trial)
Chemical References
  • Blood Glucose
  • Insulin
  • Triglycerides
  • Fructosamine
  • Arginine
Topics
  • Administration, Oral
  • Arginine (administration & dosage)
  • Blood Glucose (metabolism)
  • Blood Pressure
  • Body Weight (drug effects)
  • Combined Modality Therapy
  • Diabetes Mellitus, Type 2 (diet therapy, drug therapy)
  • Diet, Reducing
  • Energy Intake
  • Exercise
  • Female
  • Fructosamine (blood)
  • Humans
  • Insulin (blood)
  • Insulin Resistance
  • Male
  • Middle Aged
  • Obesity (diet therapy, drug therapy)
  • Triglycerides (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: